Abbott Profit Rises 12 Percent In Fourth-quarter

Salon Staff
January 25, 2012 6:27PM (UTC)

WASHINGTON (AP) — Medical device and drugmaker Abbott Laboratories says its profit increased more than 12 percent in the fourth-quarter on double-digit sales growth of its top-selling drug Humira.

Abbott reported net income of $1.62 billion, or $1.02 per share, for the last three months of 2011. That's up from $1.44 billion, or 92 cents per share, in the prior-year period.


Excluding one-time items the company earned $1.45 per share. Analysts polled by FactSet expected $1.44 per share.

Revenue rose to $10.4 billion. Analysts expected revenue of $10.6 billion.

In October, Abbott said that it would spin off its branded drug business into a separate company. The split is expected before the end of the year.

As in prior quarters, top-selling anti-inflammatory drug Humira dominated the company's results, contributing over 20 percent of sales.

Salon Staff

MORE FROM Salon Staff

Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •